Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Raouf Samy Amin, MD Passive Stretch of the Chest Wall in Patients with Congenital Muscular Dystrophy Cure CMD Cure CMD - Amin 5/3/2013 - 5/2/2016 $40,000
Raouf Samy Amin, MD Impact of Treatment of Mild Sleep-Disordered Breathing on Children's Health National Institutes of Health (Children's Hospital of Philadelphia) U01 HL125295 9/4/2015 - 6/30/2020 $193,192
Kavisha Arora, PHD Personalized Medicine-Elucidating Mechanism of a Novel CF Mutation Cystic Fibrosis Foundation ARORA16F0 3/1/2016 - 2/28/2018 $46,250
Lisa A Burns, MD Transforming CF Care Through Shared Decision Making Cystic Fibrosis Foundation (University of Cincinnati) JOSEPH15QI0 1/1/2015 - 12/31/2017 $44,107
John Paul Clancy, MD CFF-TDN site Cystic Fibrosis Fdn Therapeutics, Inc AMIN09Y0/CLANCY14Y0 1/1/2013 - 12/31/2016 $96,688
John Paul Clancy, MD CFFT Biomarkers Consortium Cystic Fibrosis Fdn Therapeutics, Inc CLANCY11CS0 1/1/2011 - 12/31/2015 $46,051
John Paul Clancy, MD PROSPECT Cystic Fibrosis Fdn Therapeutics, Inc CLANCY14K1 7/1/2014 - 6/30/2019 $108,731
John Paul Clancy, MD Pilot Development of Translational Primary Human Airway Cystic Fibrosis Foundation CLANCY14XX0 7/1/2014 - 6/30/2017 $95,256
John Paul Clancy, MD Upper and Lower Airway CF Microbiome: Pediatric Subject Characterization, Sample, Acquisition and Processing Cystic Fibrosis Fdn Therapeutics, Inc CLANCY14XX1 7/1/2014 - 6/30/2016 $26,051
John Paul Clancy, MD TDC ARC Award Cystic Fibrosis Fdn Therapeutics, Inc CLANCY14Y4 12/1/2014 - 11/30/2016 $77,153
John Paul Clancy, MD Personalizing Cystic Fibrosis Research Translation Cystic Fibrosis Foundation CLANCY15R0 7/1/2015 - 6/30/2019 $470,000
John Paul Clancy, MD TDN Steering Committee Chair Cystic Fibrosis Fdn Therapeutics, Inc CLANCY16Y3 1/1/2016 - 12/31/2018 $23,138
John Paul Clancy, MD MR Predictors of Infection, Inflammation, and Structural Lung Damage in CF National Institutes of Health R01 HL116226 9/26/2012 - 6/30/2017 $482,554
Zackary Cleveland, PHD Regional Biomarkers of Peripheral Lung Disease in Cystic Fibrosis Cystic Fibrosis Fdn Therapeutics, Inc CLEVEL16A0 4/1/2016 - 3/31/2019 $108,000
Zackary Cleveland, PHD Time-Resolved 129Xe Ventilation-Perfusion MRI in Models National Institutes of Health R00 HL111217 8/15/2015 - 7/31/2018 $248,999
Daniel Grossoehme D.Min. Training Research-Literate Chaplains as Ambassadors for Spirituality and Health John Templeton Foundation (Rush Medical University Center) 51996 7/1/2015 - 6/30/2017 $8,911
William D Hardie, MD
John Paul Clancy, MD
Cincinnati Children's Summer Medical Student Respiratory Research Fellowship National Institutes of Health T35 HL113229 5/1/2016 - 4/30/2021 $68,526
James E Heubi, MD Infant Nutrition Study Cystic Fibrosis Fdn Therapeutics, Inc (Seattle Children's) BONUS11K0 12/1/2010 - 4/30/2016 $7,805
Elizabeth Kramer First and Second Year Clinical Fellowship Grant Cystic Fibrosis Foundation KRAMER14B0 7/1/2014 - 6/30/2016 $66,250
Satish K Madala, PHD Molecular Mechanisms of TGF (alpha)-Driven Pulmonary Fibrosis Parker B. Francis Fellowship Program Madala - PBF 7/1/2013 - 6/30/2016 $54,000
Gary McPhail, MD Cystic Fibrosis Center Program Accreditation And Funding Cystic Fibrosis Foundation CC160-130 7/1/2013 - 6/30/2018 $144,651
Gary McPhail, MD Implementation of the Depression & Anxiety Guidelines Cystic Fibrosis Foundation CMHC160-15 1/1/2016 - 12/31/2018 $53,246
Gary McPhail, MD CFF Success with Therapies Research Consortium - Cincinnati Children's Cystic Fibrosis Fdn Therapeutics, Inc MCPHAI14PE0 8/1/2014 - 7/31/2017 $27,000
Anjaparavanda Naren, PHD CF-Patient Specific Enteroids from Small Intestine and Colon Cystic Fibrosis Fdn Therapeutics, Inc NAREN14XX0 7/1/2014 - 6/30/2017 $223,357
Anjaparavanda Naren, PHD Inhibition of an Apical cAMP/cGMP transporter (MRP4) in the Gut induces Diarrhea National Institutes of Health R01 DK080834 9/18/2013 - 3/31/2018 $333,536
Anjaparavanda Naren, PHD LPA2 Receptor-containing Complexes in Regulating Secretory Diarrhea National Institutes of Health R01 DK093045 7/1/2015 - 6/30/2020 $351,000
Anjaparavanda Naren, PHD Characterization of an Inhibitory Protein Complex for Cystic Fibrosis Therapy National Institutes of Health (Univ of Tennessee Health Science Center) R01 HL123535 8/15/2014 - 6/30/2019 $17,539
Kai Ruppert, PHD Simultaneous Xe129 MRI of Regional Lung Ventilation and Gas Uptake in COPD National Institutes of Health (University of Virginia) R01 HL109618 12/23/2013 - 5/31/2016 $19,188
Michael Seid, PHD Enabling Uptake of a Registry-Supported Care and Learning System in the U.S. Robert Wood Johnson Foundation (Trustees of Dartmouth) 72313 12/15/2014 - 12/14/2017 $401,775
Michael Seid, PHD Measures of Hypoglycemia and Glycemic Variability Using Continuous Glucose Monitoring in the FL3X Intervention for Youth with Type 1 Diabetes The Leona M & Harry B Helmsley Charitable (University of North Carolina) 2014PG-T1D030 1/1/2014 - 12/31/2016 $10,400
Michael Seid, PHD A C3N for CF: Design and Development of a Peer-Produced Learning Health System Cystic Fibrosis Fdn Therapeutics, Inc SEID14A0 7/1/2014 - 12/31/2015 $277,355
Michael Seid, PHD A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System Cystic Fibrosis Fdn Therapeutics, Inc SEID15A0 1/1/2016 - 12/31/2018 $800,488
Michael Seid, PHD FL3X: An Adaptive Intervention to Improve Outcomes for Youth with Type 1 Diabetes National Institutes of Health (University of North Carolina) UC4 DK101132 9/15/2013 - 6/30/2018 $629,017
Jason C Woods, PHD Pathogenesis-Driven Therapeutic Development for Pulmonary Alveolar Microlithiasis National Institutes of Health (University of Cincinnati) R01 HL127455 4/1/2015 - 3/31/2020 $70,636
Jason C Woods, PHD
John Paul Clancy, MD
UTE MRI to Monitor CF Lung Disease and Response to CFTR National Institutes of Health R01 HL131012 5/1/2016 - 3/31/2021 $760,483
Jason C Woods, PHD Severe Asthma Research Program National Institutes of Health (Washington University) U10 HL109257 2/1/2013 - 5/31/2017 $8,547
Sara M Zak, MD First & Second Year Clinical Fellowship Cystic Fibrosis Foundation ZAK15B0 7/1/2015 - 6/30/2017 $61,250
Assem Ziady, PHD Dysregulation of Nrf2 in CF Epithelia National Institutes of Health R01 HL109362 4/22/2015 - 4/30/2016 $56,933
Total Annual Grant Award Dollars $6,558,063

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
John Paul Clancy, MD Eccrine $10,000
John Paul Clancy, MD Nivalis Therapeutics $209,762
John Paul Clancy, MD ProQR Therapeutics N.V. $576,112
Daniel Grossoehme, DMin Ipsos Insight, LLC $34,615
Gary McPhail, MD Parion Services, Inc. $137,420
Gary McPhail, MD Vertex Pharmaceutical Incorporated $82,381
Anjaparavanda Naren, PHD Ironwood Pharmaceuticals, Inc. $229,921
Assem Ziady, PHD Gilead Sciences, Inc. $66,650
Assem Ziady, PHD Nivalis Therapeutics $66,470
Total Annual Industry Award Dollars $1,413,330